J. Garland
Director/Board Member at CALITHERA BIOSCIENCES, INC.
Net worth: - $ as of 2024-03-30
J. Garland active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CALITHERA BIOSCIENCES, INC. | Director/Board Member | 2020-07-09 | - |
| Independent Dir/Board Member | 2020-07-09 | - | |
| DAY ONE BIOPHARMACEUTICALS, INC. | Director/Board Member | 2021-08-16 | - |
| Independent Dir/Board Member | 2021-08-16 | - | |
| ALX ONCOLOGY HOLDINGS INC. | Director/Board Member | 2022-11-27 | - |
| OLEMA PHARMACEUTICALS, INC. | Director/Board Member | 2023-10-15 | - |
| Independent Dir/Board Member | 2023-10-15 | - |
Career history of J. Garland
Former positions of J. Garland
| Companies | Position | Start | End |
|---|---|---|---|
PACT Pharma, Inc.
 PACT Pharma, Inc. Pharmaceuticals: MajorHealth Technology PACT Pharma, Inc. develops pharmaceutical products. It offers personalizes adoptive cell therapies with neoantigen-targeted T cells against cancer. The company is headquartered in South San Francisco, CA. | Director/Board Member | 2021-03-04 | 2023-01-31 |
| Chief Executive Officer | 2021-03-04 | 2023-01-31 | |
| PORTOLA PHARMACEUTICALS, INC. | Director/Board Member | 2018-10-07 | 2020-06-30 |
| Chief Executive Officer | 2018-10-07 | 2020-06-30 | |
| President | 2018-10-07 | 2020-06-30 | |
| KARYOPHARM THERAPEUTICS INC. | Director/Board Member | 2014-11-02 | 2020-05-20 |
| Independent Dir/Board Member | 2014-11-02 | 2020-05-20 | |
| RELYPSA INC | Corporate Officer/Principal | 2014-11-02 | 2017-05-10 |
| President | 2017-05-10 | 2018-09-30 | |
| EXELIXIS, INC. | Corporate Officer/Principal | 2011-10-26 | 2014-10-30 |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Training of J. Garland
| California Polytechnic State University (San Luis Obispo) | Undergraduate Degree |
| The Fuqua School of Business | Masters Business Admin |
Statistics
International
| United States | 13 |
| 2 |
Operational
| Director/Board Member | 7 |
| Independent Dir/Board Member | 4 |
| Corporate Officer/Principal | 3 |
Sectoral
| Health Technology | 11 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 6 |
|---|---|
| AMGEN INC. | Health Technology |
| EXELIXIS, INC. | Health Technology |
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| CALITHERA BIOSCIENCES, INC. | Health Technology |
| OLEMA PHARMACEUTICALS, INC. | Health Technology |
| ALX ONCOLOGY HOLDINGS INC. | Health Technology |
| Private companies | 5 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Relypsa, Inc. operates as a bio-pharmaceutical company, which engages in the development and commercialization of late-stage medicines in the iron deficiency, nephrology, and cardio-renal therapeutic areas. It offers Veltassa, a potassium binder approved for the treatment of hyperkalemia. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA. | Health Technology |
PACT Pharma, Inc.
PACT Pharma, Inc. Pharmaceuticals: MajorHealth Technology PACT Pharma, Inc. develops pharmaceutical products. It offers personalizes adoptive cell therapies with neoantigen-targeted T cells against cancer. The company is headquartered in South San Francisco, CA. | Health Technology |
| Day One Biopharmaceuticals, Inc. |
- Stock Market
- Insiders
- J. Garland
- Experience
